However, in two different dose regimens, the vaccine's efficacy was 90 per cent in one and 62 per cent in the other.
Covaxin was found to have 78 per cent efficacy against COVID-19 of any severity, 14 or more days after the second dose, and is extremely suitable for low- and middle-income countries due to easy storage requirements, said the global health body.
Bihar, Jharkhand and Uttar Pradesh have emerged as the poorest states in India, according to Niti Aayog's first Multidimensional Poverty Index (MPI) report. As per the index, 51.91 per cent population of Bihar is poor, followed 42.16 per cent in Jharkhand, 37.79 per cent in Uttar Pradesh. While Madhya Pradesh (36.65 per cent) has been placed fourth in the index, Meghalaya (32.67 per cent) is at the fifth spot. Kerala (0.71 per cent), Goa (3.76 per cent), Sikkim (3.82 per cent), Tamil Nadu (4.89 per cent) and Punjab (5.59 per cent) have registered the lowest poverty across India and are at the bottom of the index.
Billionaire Mukesh Ambani's Reliance Industries Ltd on Friday announced the buyout of British battery maker Faradion Ltd for an enterprise value of 100 million, as the oil-to-retail conglomerate continued with the acquisition of end-to-end technology for its multi-billion-dollar clean energy portfolio. Reliance New Energy Solar Ltd (RNESL), a unit of the nation's most valuable company, signed definitive agreements to acquire 100 per cent shareholding in Faradion for an enterprise value of 100 million and will invest an additional 25 million as growth capital to accelerate the commercial roll-out, the company said in a statement. Based out of Sheffield and Oxford in the UK and with its patented sodium-ion battery technology, Faradion is one of the leading global battery technology companies.
The prime minister in his intervention at the session on "global economy and global health" also flagged the issue of facilitating international travel and talked about the mechanism of mutual recognition of vaccine certification as a means of achieving this, according to the text of his intervention shared by his office.
Blood samples taken from a group of UK volunteers given a dose of the vaccine showed that it stimulated the body to produce both antibodies and 'killer T-cells', a senior source from the trial was quoted by The Daily Telegraph as saying.
The institute expects to complete both, phase-2 and 3 trials in India by the end of this year.
There is confusion over the United Kingdom government's vaccine recognition process for Indian travellers as even though Oxford/AstraZeneca Covishield, the India-manufactured Oxford/AstraZeneca COVID-19 vaccine, is on an updated international travel advisory, India is not yet on a list of 17 approved countries.
India will be within its rights to initiate reciprocal measures if the UK does not address concerns over the new travel rules relating to COVID-19 vaccine certification, foreign secretary Harsh Vardhan Shringla said on Tuesday describing the policy as "discriminatory".
The comments by a spokesperson in the British High Commission in New Delhi came amid concerns in India over the latest Covid-related travel restrictions announced by the UK.
Amid reports of the ongoing coal shortage in the country, Finance Minister Nirmala Sitharaman stressed that there is no shortage and termed these as "absolutely baseless", saying India is a power surplus country. Sitharaman said that Power Minister R K Singh went on record just two days ago when he said absolutely baseless information is floating around that there is probably shortage of coal, shortage of other inventories which will lead to a sudden gap in the supply demand situation in the energy consumption. "Absolute baseless! There is no shortage of anything. In fact, if I recall the minister's statement, every power producing installation has the next four days' stock absolutely available within their own premises and the supply chain has not broken at all," Sitharaman said at Harvard Kennedy School on Tuesday.
The youngest Nobel Peace Prize winner who once took a bullet for campaigning for girls' education in Pakistan, was over the moon on Friday after completing her degree in Philosophy, Politics and Economics at Britain's prestigious Oxford University.
The Serum Institute of India, the largest vaccine maker in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the vaccine once it is ready. Trials results for the first two phases were published earlier this month.
Putting an end to the vaccine certification row, the UK on Thursday announced that Indians, fully vaccinated with Covishield vaccine, will no longer require to undergo quarantine on their arrival in Britain from October 11.
Australia's medicines and medical devices regulator on Monday formally recognised India's Covaxin, a vaccine against the coronavirus as the country's border was reopened for the first time in nearly 20 months.
Some important simple truths about the issue may be more helpful than high sounding debates, asserts Mohammad Sajjad.
The results show they induced strong antibody and T-cell immune responses for up to 56 days after they were given. T-cells are crucial for maintaining protection against the virus for years.
The UK government is under increasing pressure on Monday to review its COVID-19 vaccine protocol in place for travellers from India, after its updated rules effective from next month failed to recognise Indian vaccines under an expanded list of countries.
The Centre is looking to procure around 1 billion syringes between September and December to support the COVID-19 vaccination drive.
'The uneducated think of their rights as a gift. This is deeply troubling.' 'If they were educated they could claim what is rightfully theirs.'
The Pune-based company's chief executive Adar Poonawalla said the company, which is the largest vaccine maker in the world, is putting $200 million at risk by manufacturing nearly 300 million doses before the final nod to launch the vaccine in market, which is expected at best by the end of the year.
Doses of the vaccine were given to 1,077 healthy adults aged between 18 and 55 in five United Kingdom hospitals in April and May as part of the phase one clinical trial.
The United Kingdom government has pledged 20 million to support the "ChAdOx1 nCoV-19" coronavirus vaccine trial programme, with UK Health Secretary Matt Hancock saying the government would "throw everything at" finding a vaccine against the deadly virus.
Barbie has unveiled their #ThankYouHeroes global doll series featuring frontline workers.
A technical advisory group of the UN health agency which met on Tuesday has sought "additional clarifications" from Bharat Biotech for Covaxin to conduct a final "risk-benefit assessment" for Emergency Use Listing of the vaccine.
British nationals arriving in India, irrespective of their vaccination status, will have to undergo 10 days of mandatory quarantine from October 4 as part of the reciprocal actions initiated by the government following the vaccine certification row between the two countries.
PHE estimates that the vaccination programme in England has prevented 22 million infections, around 52,600 hospitalisations and between 35,200 and 60,000 deaths.
Did Prime Minister Modi receive a different kind of reception at the Biden White House on Friday than he has has been used to at the American president's home?
The new malaria vaccine (RTS.S/ AS01, tentatively brand-named Mosquirix) is the very first one to offer immunity against a parasite -- specifically the plasmodium falciparum parasite, which is the deadliest of the five parasites that cause malaria.
But no extra risk after second dose, shows study led and funded by drug maker, reports Sohini Das.
The researchers found that after being exposed to high levels of the novel coronavirus, none of the six monkeys that were given the vaccine developed viral pneumonia. Also, there was no sign that the vaccine had made the animals more vulnerable.
The protection gained after being fully vaccinated with both doses of the Pfizer/BioNTech and Oxford/AstraZeneca vaccines against Covid-19 wanes over time, a new UK study reported on Wednesday.
"I realise that a lot of Indians who have taken Covishield are facing issues with travel to the EU, I assure everyone, I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries," Poonawalla said in a tweet.
It's not every day that an undergraduate from India wins a scholarship to study at one of the prestigious universities in the world.
"The vaccination schedule is considered complete 28 days after the administration of a dose for Janssen vaccine and 7 days after administration of a second dose for other vaccines (Pfizer / Comirnaty, Moderna, AstraZeneca/Vaxzevria/Covishield)," the statement added.
Akanksha Mary Balmuchu from Jharkhand's Ho tribe is starting a Master's programme in climate change in the UK. When she walks into campus, she fulfils not only her dream, but that of her grandmother.
The international team of researchers combined lab-based experiments and epidemiology of vaccine breakthrough infections, showing that the Delta variant is better at replicating and spreading than other commonly-observed variants.
This means fully vaccinated Indian passengers will no longer be subjected to a compulsory 10-day hotel quarantine on their arrival in Britain.
If confirmed by the Senate, Garcetti, 50, would replace Kenneth Juster, who served as India's Ambassador to the US during the Trump administration.
In September, Bharat Biotech aimed to supply 35 million doses, and take this up to 55 million by October. This is still less than what the Indian government expects from the company.
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances